1 study found for:    23602668 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants
Condition: Healthy
Interventions: Biological: MEDI-534, Cohort 1;   Other: Placebo, Cohort 1;   Biological: MEDI-534, Cohort 2;   Other: Placebo, Cohort 2;   Biological: MEDI-534, Cohort 3;   Other: Placebo, Cohort 3;   Biological: MEDI-534, Cohort 4;   Other: Placebo, Cohort 4;   Biological: MEDI-534, Cohort 5;   Other: Placebo, Cohort 5

Indicates status has not been verified in more than two years